As the world ponders the possibility of GFC2 its population just keeps on growing at a rate of about 2.5million people per week.
In a nutshell the world of diagnostics just keeps on growing its customer base.
All holds up well if your a Company with the ability to seize a large exposure in this market.
At a 20% discount to where it was only two weeks ago, I suspect the risk reward ratio has improved significantly for this stock based upon the same fundamentals it had two weeks ago.
Other than that - nothing has changed - still awaiting for a sign of ink on paper.
IMO
DYOR
point to ponder whilst things are quiet
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.002(8.70%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $20.83K | 964.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2247357 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 164375 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |